Medical/Pharmaceuticals

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP

STOCKHOLM, Aug. 2, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Southern Airlines has approved the Envirotainer Releye® RLP for usage on their fleet of aircrafts. With this approval...

2021-08-02 14:28 2314

Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

TIBSOVO is the first targeted therapy to show improved event-free survival and overall survival in combination with azacitidine compared to azacitidine monotherapy. Safety profile consistent with previously published data in patients with IDH1-mutated acute myeloid leukemia. The study recently ...

2021-08-02 14:00 3506

LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic

SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis (NASH). ...

2021-08-02 11:11 1955

Luye Pharma Enters Distribution Agreement with Zuellig Pharma for Seroquel and Seroquel XR in Malaysia and Brunei, Strengthening Business Presence in Asia Pacific and Improving Access to Evidence-Based Medical Treatments for Mental Health

SUBANG JAYA, Malaysia, Aug. 2, 2021 /PRNewswire/ -- Luye Pharma Group today announced that it has entered into an agreement with Zuellig Pharma, a leading healthcare service group inAsia, under which the company grants Zuellig Pharma exclusive rights to distribute its central nervous system drugs...

2021-08-02 10:25 5703

Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

SEOUL, South Korea and SHANGHAI and HONG KONG, Aug. 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics i...

2021-08-02 07:29 6475

Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities

Led by Optum Ventures and Oxford Sciences Innovation, new funding will propel Rey's launch of a tech-enabled, on-demand mental health clinic in response to growing demand for high-quality care in an increasingly resource constrained market AUSTIN, Texas, July 31, 2021 /PRNewswire/ -- Rey, a new ...

2021-07-31 02:56 4692
1 ... 643644645646647